Exact Sciences Corp. Company Profile (NASDAQ:EXAS)

Analyst Ratings

Consensus Ratings for Exact Sciences Corp. (NASDAQ:EXAS) (?)
Ratings Breakdown: 7 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $11.77 (5.54% downside)

Analysts' Ratings History for Exact Sciences Corp. (NASDAQ:EXAS)
Show:
DateFirmActionRatingPrice TargetActions
7/15/2016William BlairReiterated RatingOutperform$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Craig HallumReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Robert W. BairdReiterated RatingOutperform$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Roth CapitalReiterated RatingHold$7.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Jefferies GroupReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Canaccord GenuityReiterated RatingBuy$9.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016MizuhoReiterated RatingHold$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016BTIG ResearchReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$8.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016StephensDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Benchmark Co.Reiterated RatingHold$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Lake Street CapitalReiterated RatingHold$12.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015WedbushLower Price Target$7.00 -> $6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015JMP SecuritiesBoost Price TargetOutperform$27.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Maxim GroupBoost Price TargetSell$8.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Exact Sciences Corp. (NASDAQ:EXAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
7/26/2016Q216($0.55)($0.46)$18.54 million$21.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2016Q116($0.52)($0.49)$15.17 million$14.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q415($0.47)($0.41)$14.96 million$14.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315($0.44)($0.45)$12.56 million$12.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2015Q215($0.45)($0.44)$7.96 million$8.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015Q115($0.41)($0.40)$4.11 million$4.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.04)($0.38)$19.90 million$1.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014Q314($0.32)($0.39)$0.13 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2014Q214($0.25)($0.24)$0.03 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114($0.19)($0.23)$0.40 million$0.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2014Q413($0.19)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.18)($0.16)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2013Q2 2013($0.18)($0.19)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013($0.20)($0.17)$1.02 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2013Q4 2012($0.18)($0.22)$1.04 million$1.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2012Q312($0.21)($0.21)$1.03 million$1.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012($0.20)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.18)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.15)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.10)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.09)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.08)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Exact Sciences Corp. (NASDAQ:EXAS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166($0.54)($0.46)($0.51)
Q2 20164($0.56)($0.54)($0.55)
Q3 20164($0.55)($0.47)($0.52)
Q4 20164($0.55)($0.40)($0.50)
Q1 20172($0.44)($0.35)($0.40)
Q2 20172($0.42)($0.34)($0.38)
Q3 20172($0.40)($0.35)($0.38)
Q4 20172($0.38)($0.36)($0.37)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Exact Sciences Corp. (NASDAQ:EXAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Exact Sciences Corp. (NASDAQ:EXAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/1/2016D Scott CowardSVPSell1,685$6.62$11,154.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016D Scott CowardSVPSell2,175$6.05$13,158.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Graham Peter LidgardInsiderSell3,041$6.05$18,398.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Maneesh AroraCOOSell4,042$6.05$24,454.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016James Edward DoyleDirectorBuy5,000$6.43$32,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016Katherine S NapierDirectorBuy3,775$5.38$20,309.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016Kevin T ConroyCEOBuy50,000$5.00$250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Kevin T ConroyCEOSell6,895$5.81$40,059.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Graham Peter LidgardInsiderSell2,997$5.52$16,543.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Maneesh AroraCOOSell4,099$5.52$22,626.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Graham Peter LidgardInsiderSell2,411$6.39$15,406.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Kevin T ConroyCEOSell6,866$6.39$43,873.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Maneesh AroraCOOSell2,556$6.39$16,332.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016David ThompsonDirectorBuy15,000$6.99$104,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Graham Peter LidgardDirectorSell3,938$23.44$92,306.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Kevin T ConroyCEOSell8,425$23.44$197,482.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Maneesh AroraCOOSell3,895$23.44$91,298.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Graham Peter LidgardDirectorSell4,037$22.90$92,447.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Kevin T ConroyCEOSell9,798$22.90$224,374.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Maneesh AroraCOOSell2,995$22.90$68,585.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Graham Peter LidgardInsiderSell3,363$26.72$89,859.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Kevin T ConroyCEOSell9,484$26.72$253,412.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Maneesh AroraCOOSell2,495$26.72$66,666.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Graham Peter LidgardInsiderSell8,015$24.68$197,810.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Graham Peter LidgardVPSell11,081$15.99$177,185.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Kevin T ConroyCEOSell11,336$15.99$181,262.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Maneesh AroraCOOSell9,291$15.99$148,563.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014William MeganSVPBuy10,000$11.79$117,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Graham Peter LidgardVPSell3,160$14.07$44,461.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Kevin ConroyCEOSell8,708$14.07$122,521.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Maneesh AroraCOOSell2,662$14.07$37,454.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Graham Peter LidgardVPSell10,288$11.96$123,044.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Kevin ConroyCEOSell26,379$11.96$315,492.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Maneesh AroraCOOSell8,627$11.96$103,178.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Graham Peter LidgardVPSell7,430$11.07$82,250.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Sally CrawfordDirectorSell25,000$12.19$304,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2012Kevin T ConroyCEOBuy2,000$9.13$18,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2012Maneesh AroraCFOBuy1,000$9.04$9,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Lionel SterlingDirectorBuy5,500$9.08$49,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Exact Sciences Corp. (NASDAQ:EXAS)
DateHeadline
07/26/16 04:08 AMExact Sciences Completes 54,000 Cologuard Tests during the Second Quarter - [at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
07/26/16 04:07 AMExact Sciences reports 2Q loss -
07/25/16 07:24 AMWhat's in Store for these 5 Drug Stocks in Q2 Earnings? -
07/21/16 09:26 PMMarket Minute - Focus on EXACT Sciences Corporation (NASDAQ:EXAS) Stock - TGP
07/21/16 09:26 PMTwo Stocks within Analysts Review: EXACT Sciences Corporation (NASDAQ:EXAS) , PTC Therapeutics, Inc. (NASDAQ ... - Street Updates
07/21/16 09:26 PMExact Sciences Corporation (NASDAQ:EXAS) at $12.61: How much higher it can go - Review Fortune
07/21/16 04:05 PMEXACT Sciences Corporation : half-yearly earnings release
07/20/16 05:15 PMEXACT Sciences Corporation (NASDAQ:EXAS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 05:15 PMAnalysts Reviewing Stocks Update: UnitedHealth Group Incorporated (NYSE:UNH) , EXACT Sciences Corporation ... - Street Updates
07/20/16 05:15 PMExact Sciences Corporation (NASDAQ:EXAS) Sellers Increased By 50.48% Their Shorts - Press Telegraph
07/19/16 09:12 PMSession Focus - Highlighting Shares of: EXACT Sciences Corporation (NASDAQ:EXAS) - TGP
07/19/16 10:00 AMConsensus Analyst Target Price Check for EXACT Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/19/16 10:00 AMHow Analysts Rated EXACT Sciences Corporation (NASDAQ:EXAS) Last Week? - Press Telegraph
07/19/16 10:00 AMHC Stocks Reports: Lpath, Inc. (NASDAQ:LPTN), EXACT Sciences Corporation (NASDAQ:EXAS) - share market updates (press release)
07/18/16 04:04 PMEXACT Sciences Corporation (NASDAQ:EXAS) Taking a Look at the Current Company Impact Score - Press Telegraph
07/18/16 04:04 PMMarket Motion Watch - Focus on Shares of: EXACT Sciences Corporation (NASDAQ:EXAS) - TGP
07/18/16 04:04 PMShare Performance Summary for: Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/18/16 04:04 PMTracking Trading Performance for: EXACT Sciences Corporation (NASDAQ:EXAS) - TGP
07/18/16 04:04 PMStocks Movements to Focus: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , EXACT Sciences Corporation ... - Street Updates
07/18/16 04:04 PMAnalyst Recommendations Watch: Exact Sciences Corporation (NASDAQ:EXAS) - News Oracle
07/15/16 02:58 PMMoving Stock in Focus: Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/15/16 02:58 PMAnalysts Rating Overview: Gilead Sciences, Inc. (NASDAQ:GILD) , EXACT Sciences Corporation (NASDAQ:EXAS) - Street Updates
07/14/16 07:09 AMStocks within Analysts Screening: EXACT Sciences Corporation (NASDAQ:EXAS) , Nektar Therapeutics (NASDAQ ... - Street Updates
07/14/16 07:09 AMPrice Target in the Spotlight: Exact Sciences Corporation (NASDAQ:EXAS) - News Oracle
07/14/16 07:09 AMShort Term Rating on EXACT Sciences Corporation (EXAS) - Trade Calls
07/14/16 07:09 AMEXACT Sciences Corporation (NASDAQ:EXAS) & Mobileye NV (NYSE:MBLY) Stocks Trending Alert - Money News (press release)
07/13/16 04:13 PMIllumina (ILMN) Rallies On Exact Sciences Buyout Rumor
07/13/16 04:13 PMEXACT Sciences Corporation (NASDAQ:EXAS): Our members Are Already Up 8% In One Session
07/13/16 12:48 PMNCQA Proposes Inclusion of Cologuard in 2017 HEDIS Quality Measures - [at noodls] - 06/01/2016 Cologuard Available In-Network for Anthem Blue Cross and Blue Shield Members in Five Additional Midwest States Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage ...
07/13/16 12:21 PM1:21 pm EXACT Sciences announces the NCQA has proposed to include Cologuard on a 3-year schedule -
07/13/16 11:54 AMBetter Buy: Exact Sciences Corporation vs. Quest Diagnostics - Does recent news for Exact Sciences make it a better buy now than this diagnostic industry heavyweight?
07/13/16 05:55 AMHC Stocks Buzzer: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), EXACT Sciences Corporation (NASDAQ:EXAS) - share market updates (press release)
07/12/16 04:06 PMEXACT Sciences Corporation (NASDAQ:EXAS): Recent Share Performance Watch - Press Telegraph
07/12/16 03:15 PMExact Sciences (EXAS) Stock Rising on Illumina Takeover Speculation -
07/12/16 08:21 AMCompany Shares of EXACT Sciences Corporation (NASDAQ:EXAS) Rally 0.97% - Trade Calls
07/12/16 08:21 AMHC Stocks Highlights: Sarepta Therapeutics Inc (SRPT), EXACT Sciences (EXAS) - share market updates (press release)
07/11/16 08:44 AMKeep an eye on Analyst Actions: Gilead Sciences, Inc. (NASDAQ:GILD) , EXACT Sciences Corporation (NASDAQ:EXAS) - Street Updates
07/11/16 08:44 AMStock Performance Rundown on: Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/10/16 03:42 PMCompany Share Performance in Review: Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/10/16 03:42 PMEXACT Sciences Corporation (NASDAQ:EXAS): Check on Company Stock Performance - Press Telegraph
07/10/16 03:42 PMNext Weeks Broker Price Targets For EXACT Sciences Corporation (EXAS) - Fiscal Standard
07/08/16 03:56 PMHC Stocks Outlines: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), EXACT Sciences Corporation (NASDAQ:EXAS) - share market updates (press release)
07/08/16 03:56 PMNews Sentiment and Impact Score Review for :EXACT Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/08/16 03:56 PMAnalyst Rating Fluctuations to Observe: EXACT Sciences Corporation (NASDAQ:EXAS) , Progenics Pharmaceuticals ... - Street Updates
07/08/16 05:57 AMTrading Update: Share Performance Recap for Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/08/16 05:57 AMTwo Buzzers within Analysts Radar: Celgene Corporation (NASDAQ:CELG) , EXACT Sciences Corporation (NASDAQ ... - Street Updates
07/08/16 05:57 AMHC Stocks Updates: EXACT Sciences Corporation (NASDAQ:EXAS), AbbVie Inc (NYSE:ABBV) - share market updates (press release)
07/07/16 03:58 PMCommit To Buy EXACT Sciences Corp. At $8, Earn 19.4% Using Options
07/06/16 09:46 PMInsiders Increasing Positions in: Exact Sciences Corporation (NASDAQ:EXAS) - Press Telegraph
07/06/16 08:39 AMRecent Analysts Ratings Fluctuations: EXACT Sciences Corporation (NASDAQ:EXAS) , Heartware International, Inc ... - Street Updates

Social

About Exact Sciences Corp.

Exact Sciences Corp. logoExact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some forms of cancer. The Company's product pipeline includes Lung Cancer Nodules, Pancreatic Cancer Screening, Esophageal Cancer Screening, Lung Cancer Pipeline, Pancreatic Cancer Pipeline and Esophageal Cancer Pipeline. It has developed a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a non invasive stool based deoxyribonucleic acid (DNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. The United States Food and Drug Administration (FDA) approved Cologuard for use as sDNA non-invasive colorectal cancer screening test. Cologuard is available through healthcare providers. It also focused on developing its pipeline for future products and services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: EXAS
  • CUSIP: 30063P10
Key Metrics:
  • Previous Close: $12.48
  • 50 Day Moving Average: $10.99
  • 200 Day Moving Average: $7.59
  • P/E Ratio: N/A
  • P/E Growth: -0.27
  • Market Cap: $1.22B
  • Beta: 0.99
  • Current Year EPS Consensus Estimate: $-2.03 EPS
  • Next Year EPS Consensus Estimate: $-1.76 EPS
Additional Links:
Exact Sciences Corp. (NASDAQ:EXAS) Chart for Tuesday, July, 26, 2016